Information  X 
Enter a valid email address

Arix Bioscience PLC (ARIX)

  Print   

Monday 16 August, 2021

Arix Bioscience PLC

Director/PDMR Shareholding

Arix Bioscience PLC (ARIX)
Director/PDMR Shareholding

16-Aug-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


Arix Bioscience plc

Director/PDMR Shareholding

 

 

Arix Bioscience plc (the "Company") today announces the annual award of nil cost options to Interim CEO Robert Lyne, which are subject to performance conditions over a three-year assessment period, in accordance with the Company's Remuneration Policy.

 

PDMR DEALING NOTIFICATION

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Lyne

2

Reason for the notification

a)

Position / status

Interim Chief Executive Officer

b)

Initial notification /

Amendment

Initial Notification

3

Details of issuer

a)

Name

Arix Bioscience plc

b)

LEI

213800OVT3AHQCXNIX43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of Arix Bioscience plc

Identification code

GB00BD045071

b)

Nature of the transaction

Award of nil-cost options under the Arix Bioscience plc Executive Incentive Plan ("EIP") 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

352,335

d)

Aggregated information

Aggregated price

Aggregated volume

N/A (single transaction)

N/A (single transaction)

e)

Date of the transaction

13 August 2021

f)

Place of the transaction

Outside a trading venue

 

 

 

 

For further information please contact:

 

Optimum Strategic Communications

Mary Clark, Manel Mateus

+44 (0)20 8078 4357

[email protected] 

 - Ends -



ISIN: GB00BD045071
Category Code: DSH
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 2.3. Major shareholding notifications
Sequence No.: 119950
EQS News ID: 1226354

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1226354&application_name=news&site_id=financialexpress

a d v e r t i s e m e n t